Home / Pharmaceutical company intelligence
Scotmann Pharmaceuticals logo
Pharmaceutical company intelligence

Scotmann Pharmaceuticals

Pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-based pharmaceutical manufacturer with general medicines and nutraceutical products, nationwide distribution and accredited quality-control capabilities.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
5-D, I-10/3, Industrial Area, Islamabad, Pakistan
Phone
+92 51 4430626
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000498 Scotmann Pharmaceuticals. · Islamabad
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000498 161 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx161public portfolio records represented
REG122unique registrations represented
IDX158indexed MedInfoBase presentations
SRC3additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR152current validated price records
G57generic molecules in indexed catalogue
DF9dosage-form groups
TA13therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage94%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage89%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixScotmann PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 23 Sep 2026Anti-infectives56 · 35%Hematology & thrombosis21 · 13%Cardiovascular21 · 13%Gastrointestinal & hepatology11 · 7%Vitamins, minerals & nutrition11 · 7%CNS & mental health10 · 6%Oncology & immunology9 · 6%Other therapeutic areas19 · 12%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioScotmann PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 23 Sep 2026158presentationsTablet99 · 63%Capsule24 · 15%Suspension13 · 8%Injection10 · 6%Infusion5 · 3%Sachet2 · 1%Other forms5 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionScotmann PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 23 Sep 2026140comparable productsBelow peer median50 · 36%Near peer median53 · 38%Above peer median37 · 26%Company median price position-1.7%Lowest-price equivalents20Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsScotmann PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/scotmann-pharmaceuticalsGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,31 shared54% overlapWerrick Pharmaceuticals30 shared53% overlapGenome Pharmaceuticals (Pvt.) Ltd.30 shared53% overlapMediate Pharmaceutical Pvt Ltd29 shared51% overlapNeutro Pharma (Pvt.) Ltd.,29 shared51% overlapCCL Pharmaceuticals (Pvt.) Limited28 shared49% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives56 products · 35%
Hematology & thrombosis21 products · 13%
Cardiovascular21 products · 13%
Gastrointestinal & hepatology11 products · 7%
Vitamins, minerals & nutrition11 products · 7%
CNS & mental health10 products · 6%
Oncology & immunology9 products · 6%
Endocrine & metabolic8 products · 5%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials15 products · 9%
Anticoagulants14 products · 9%
Antivirals12 products · 8%
Vitamins / minerals / hematinics11 products · 7%
Macrolide antibacterials7 products · 4%
Antiplatelet medicines7 products · 4%
Antipsychotics7 products · 4%
Third-generation cephalosporins6 products · 4%
Formulation footprint

Dosage forms

Tablet99 products
Capsule24 products
Suspension13 products
Injection10 products
Infusion5 products
Sachet2 products
Solution2 products
Syrup2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 RivascotRivaroxaban 12presentations 10 mg, 15 mg, 2.5 mg, 20 mg · Tablet #2 AmityCiprofloxacin 7presentations 100 mg/50 mL, 125 mg/5 mL, 200 mg/100 mL, 250 mg · Infusion, Suspension, Tablet #3 CefiscotCefixime 6presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule #4 BoldOmeprazole 5presentations 10 mg, 20 mg, 40 mg · Capsule #5 LeafAmlodipine 5presentations 10 mg, 2.5 mg, 5 mg · Tablet #6 MetscotMetformin 5presentations 1000 mg, 250 mg, 500 mg, 850 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median5036% of comparable products
Near market median53within ±5% of median
Above market median3726% of comparable products
Lowest-price equivalents20ties included
Company median price position -1.7% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Metscot 1000 mgMetformin · Extended-release tablet · 50's PKR 2.94/tablet-78.9% vs market median Senora 2.5 mgLetrozole · Tablet · 10's PKR 134.74/tablet-67.1% vs market median Cycloscot 100 mgCiclosporin · Capsule · 5x10's PKR 110.80/capsule-63.2% vs market median Dobro 25 mgSpironolactone · Tablet · 100's PKR 2.12/tablet-57.2% vs market median Enzimox 250 mgAmoxicillin · Capsule · 2×10’s PKR 5.28/capsule-53.2% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 31shared generics Werrick Pharmaceuticals249 products · 82 generics 30shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 30shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 29shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 29shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 28shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers121Distinct registrations among indexed, published, presentation-validated products only
Verified price observations287
Products with a verified price158
Products with multiple price observations129
Source records with multiple versions156
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

122 unique registration(s) · 158 indexed presentation(s) · 3 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Advance Fluoxetine 20 mg Capsule 1x10's 028257 PKR 194.14 PKR 19.41/capsule 50% above median
Amity Ciprofloxacin 250 mg Tablet 1x10's 028210 PKR 339.77 PKR 33.98/tablet 35% above median
Amity Ciprofloxacin 500 mg Tablet 1x10's 028211 PKR 630.99 PKR 63.10/tablet 48% above median
Amity Ciprofloxacin 750 mg Tablet 1x10's 028212 PKR 830.97 PKR 83.10/tablet 110% above median
Amity Ciprofloxacin 125 mg/5 mL Suspension 60ml 028213 PKR 174.74 PKR 2.91/mL 18% below median
Amity Ciprofloxacin 250 mg/5 mL Suspension 60ml 028214 PKR 310.64 PKR 5.18/mL Near median
Amity Ciprofloxacin 200 mg/100 mL IV infusion 100ml 054684 PKR 239.32 PKR 2.39/mL 6% above median
Amity Ciprofloxacin 100 mg/50 mL IV infusion 50ml 056808 PKR 105.58 PKR 2.11/mL 14% below median
Amity XR Ciprofloxacin 500 mg Extended-release tablet 10's 031066 PKR 480.11 PKR 48.01/tablet 11% below median
Amity XR Ciprofloxacin 1000 mg Extended-release tablet 10's 046251 PKR 553.98 PKR 55.40/tablet 23% below median
Anna Anastrozole 1 mg Tablet 28's 090104 PKR 8,841.44 PKR 315.77/tablet 7% below median
Anna Anastrozole 1 mg Tablet 10's, 090104 PKR 3,157.67 — No comparator
Aziscot Azithromycin 250 mg Tablet 6's 102632 PKR 277.00 PKR 46.17/tablet Near median
Aziscot Azithromycin 500 mg Tablet 6's 102633 PKR 507.81 PKR 84.64/tablet Near median
Aziscot Azithromycin 200 mg/5 mL Oral suspension 30 ml 102637 PKR 597.16 PKR 19.91/mL Near median
Aziscot Azithromycin 200 mg/5 mL Oral suspension 15ml 102637 PKR 304.68 PKR 20.31/mL Near median
Benzer Benzoyl peroxide 10 % Topical solution 90ml 048944 PKR 738.63 PKR 8.21/mL No comparator
Bold Omeprazole 10 mg Capsule 14’s 028237 PKR 138.50 PKR 9.89/capsule 30% below median
Bold Omeprazole 20 mg Capsule 2x7's 028238 PKR 271.80 PKR 19.41/capsule Near median
Bold Omeprazole 20 mg Capsule 100's 028238 PKR 1,863.77 PKR 18.64/capsule 5% below median
Bold Omeprazole 40 mg Capsule 14's 028239 PKR 524.20 PKR 37.44/capsule 8% above median
Bold Omeprazole 40 mg Capsule 100's 028239 PKR 3,594.56 PKR 35.95/capsule Near median
C-Eff Ascorbic acid 500 mg Chewable tablet 40's 107078 PKR 47.83 PKR 1.20/tablet 10% below median
Carbascot Carbamazepine 200 mg Sustained-release tablet 3x10's 031072 PKR 304.68 PKR 10.16/tablet No comparator
Carbascot Carbamazepine 400 mg Sustained-release tablet 3x10's 031073 PKR 355.66 PKR 11.86/tablet No comparator
Cefiscot Cefixime 400 mg Capsule 1x5's 029900 PKR 564.16 PKR 112.83/capsule Near median
Cefiscot Cefixime 100 mg/5 mL Suspension 60 ml 029901 PKR 421.82 PKR 7.03/mL 33% below median
Cefiscot Cefixime 100 mg/5 mL Suspension 30ml 029901 PKR 285.18 PKR 9.51/mL 9% below median
Cefiscot Cefixime 200 mg/5 mL Suspension 30ml 068704 PKR 385.28 PKR 12.84/mL Near median
Cefiscot Cefixime 200 mg Capsule 10x10's 083487 PKR 5,083.65 PKR 50.84/capsule 19% below median
Cefiscot Cefixime 200 mg Capsule 10's 083487 PKR 535.72 PKR 53.57/capsule 15% below median
Clopiscot Clopidogrel 75 mg Tablet 28's 028954 PKR 720.18 PKR 25.72/tablet 5% below median
Cona Scot Fluconazole 150 mg Capsule 1's 034955 PKR 230.82 PKR 230.82/capsule 13% below median
Coscot Chloroquine 250 mg Tablet 500's 102293 PKR 757.28 PKR 1.51/tablet Near median
Coscot H Hydroxychloroquine 200 mg Tablet 50's 102292 PKR 830.97 PKR 16.62/tablet 15% above median
Coscot H Hydroxychloroquine 200 mg Tablet 30's 102292 PKR 498.59 PKR 16.62/tablet 15% above median
Cycloscot Ciclosporin 10 mg Capsule 6x10's 028917 PKR 1,384.95 PKR 23.08/capsule 30% below median
Cycloscot Ciclosporin 25 mg Capsule 5x10's 028918 PKR 2,769.88 PKR 55.40/capsule 26% below median
Cycloscot Ciclosporin 100 mg Capsule 5x10's 028919 PKR 5,539.76 PKR 110.80/capsule 63% below median
Cycloscot Ciclosporin 100 mg/5 mL Solution 60ml 028920 PKR 1,384.95 PKR 23.08/mL No comparator
Dascot Daclatasvir 30 mg Tablet 28's 087764 PKR 5,137.20 PKR 183.47/tablet Near median
Dascot Daclatasvir 60 mg Tablet 28’s 087765 PKR 8,837.71 PKR 315.63/tablet Near median
Diabescot -XR Metformin 500 mg Extended-release tablet 5x10's 035800 PKR 147.14 PKR 2.94/tablet Near median
Direa-X Loperamide HCl 2 mg Capsule 50's 050165 PKR 274.78 PKR 5.50/capsule 8% above median
Direa-X Loperamide HCl 2 mg Capsule 10's 050165 PKR 57.25 PKR 5.73/capsule 12% above median
Direa-X Loperamide HCl 2 mg Capsule 30's 050165 PKR 164.86 PKR 5.50/capsule 8% above median
Dobro Spironolactone 25 mg Tablet 100's 098154 PKR 212.36 PKR 2.12/tablet 57% below median
Dobro Spironolactone 100 mg Tablet 10's 113369 PKR 123.92 PKR 12.39/tablet 15% below median
Ecru Apixaban 2.5 mg Tablet 30's 104690 PKR 4,333.93 PKR 144.46/tablet 26% above median
Ecru Apixaban 5 mg Tablet 30's 104691 PKR 4,607.23 PKR 153.57/tablet 26% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Scotmann Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/scotmann-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.